Ani Pharmaceuticals (ANIP) Dividend Coverage Ratio (QoQ) (2022 - 2025)
Powered by 
Analysis
Ani Pharmaceuticals (ANIP) Dividend Coverage Ratio (QoQ) (2022 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.63 Bn | 38.98 Bn | 2.15 Bn |
| 2 | Viatris | 19.18 Bn | 18.30 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.68 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.36 Bn | 522.63 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 995.08 Mn | 704.96 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 406.65 Mn | 365.40 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 176.59 Mn | 176.59 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 281.78% |
| Jun 30, 2025 | -46.83% |
| Mar 31, 2025 | 243.00% |
| Dec 31, 2024 | 56.53% |
| Sep 30, 2024 | -814.35% |
| Jun 30, 2024 | -115.10% |
| Mar 31, 2024 | 2,276.64% |
| Dec 31, 2023 | -92.14% |
| Sep 30, 2023 | 63.71% |
| Jun 30, 2023 | 463.76% |
| Mar 31, 2023 | 122.27% |
| Dec 31, 2022 | 48.49% |
| Sep 30, 2022 | 41.11% |
| Jun 30, 2022 | 25.71% |
| Mar 31, 2022 | 60.40% |